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Abstract
The leptin receptor (OBR) and its ligand leptin (OB) are key players in the regulation of body weight. The OBR is a
member of the class I cytokine receptor family and is alternatively spliced into at least six different isoforms. The multiple
forms are identical in their extracellular and transmembrane regions but differ in lengths. The two predominant isoforms
include a long form (OBRl) with an intracellular domain of 303 amino acids and a shorter form (OBRs) with an intracellular
domain of 34 amino acids. We have constructed a recombinant OBRl chimera with the green fluorescent protein (GFP) by
fusing GFP to the C-terminus of the OBRl. The OBRl-GFP chimera was transiently transfected and expressed in SHSY5Y
and HEK293 cells. In a STAT-Luciferase assay we show that the GFP moiety in this chimera did not affect the signalling
capacity of OBRl-GFP. In both SHSY5Y and HEK293 cells transfected with OBRl-GFP, a predominant intracellular green
OBRl-GFP fluorescence was detected in vesicles also positive for internalized fluorophore conjugated leptin. We also found
that treatment with the lysosomotropic reagent monensin did not relocalize OBRl-GFP together with the human transferrin
receptor in recycling endosomes, indicating OBRl-GFP not to participate in this pathway. In biotinylation-streptavidin pulse
chase experiments, using antibodies raised against GFP and OBR, we observed that the rate of early appearance of OBRs at
the cell surface, upon leptin stimulation, was faster than that found for OBRl-GFP. Taken together, our results provide novel
data concerning the intracellular trafficking of the two different isoforms of the leptin receptor. ß 2000 Elsevier Science
B.V. All rights reserved.
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1. Introduction
The leptin receptor (OBR), a member of the cyto-
kine receptor family, is a product from the diabetes
(db) gene, which encodes several di¡erent spliced
forms of various lengths [1,2]. The longest form of
the receptor, OBRl, has an extended cytoplasmic do-
main of 303 amino acids and is mainly expressed in
the hypothalamus where it is thought to mediate re-
duction in food intake and increased energy con-
sumption followed by weight loss [3^7]. The other
forms are shorter in their cytoplasmic tails and are
missing several motifs compared to the long form [3].
One of the shorter forms, here named OBRs, is trun-
cated at 34 amino acids in its cytoplasmic tail and is
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the most broadly expressed form [2,8,9]. All isoforms
contain a ‘box 1’ Janus kinase in the cytoplasmic tail.
OBRl also contains a ‘box 2’ motif and STAT bind-
ing sites. OBRl contains a longer cytoplasmic car-
boxyl sequence with a STAT interaction motif and
signals via the JAK-STAT pathway. It is therefore
generally believed that the OBRl is the main signal-
ling form of the receptor [10^13]. However, it has
been shown that also the shorter forms are compe-
tent in signalling [14]. Furthermore, divergent signal-
ling capacities between the di¡erent short isoforms
have been reported [15].
The major part of the cytokine receptor family is
internalized in a ligand dependent manner, via clath-
rin-coated vesicles, into early endosomes. Intracellu-
lar transport of ligand-receptor complexes is depen-
dent on an acidic environment and on speci¢c
targeting sequences in the cytoplasmic domains.
Generally, after receptor-ligand internalization, the
ligand is separated from the receptor and the recep-
tor may either shuttle to lysosomes for degradation
or e⁄ciently recycle back to the cell surface for an-
other turn of internalization. Receptor-mediated en-
docytosis and recycling of receptors contribute to
desensitization and resensitization of receptors (for
reviews see [17,18]). Thus active tra⁄cking of recep-
tors is important for regulation of cell signalling. In
previous studies on isolated brain vessels, it has been
proposed that leptin binds and endocytoses at the
blood-brain barrier and that this receptor-mediated
transport most likely is carried out by OBRs since
OBRl is absent in the brain endothelium [19].
Studies of receptor tra⁄cking with antibodies do
not always allow for e⁄cient observation of receptor
translocation in intracellular compartments. The
green £uorescent protein (GFP) from jelly¢sh is be-
coming widely used as a molecular reporter to mon-
itor gene expression, localization and intracellular
protein tra⁄cking in living cells. Many GFP-tagged
proteins retain their biological activity and have the
same tra⁄cking pattern as the native proteins
[21,22]. Moreover, the proteins that are of interest
for labelling with GFP for microscopy studies may
be endogenously expressed at relatively low levels.
Thus, the GFP labelling may make the detection of
these proteins signi¢cantly easier.
In the present study, we have constructed a func-
tional recombinant OBRl chimera with GFP. In £uo-
rescence microscopy, a predominant intracellular
green OBRl-GFP £uorescence was detected in
vesicles positive for internalized £uorescent-conju-
gated leptin.
It has been discussed whether there are di¡erences
in the intracellular tra⁄cking of OBRs and OBRl
[8,15,20]. Uotani et al. [36] recently provided a char-
acterization of the ability of OBRs and OBRl to me-
diate leptin uptake and degradation and found OBRl
to be the most e⁄ciently degraded, whereas Barr et
al. [37] were able to detect di¡erences in the internal-
ization of di¡erent OBR isoforms. To further address
this question, we have chosen to study variations in
cell surface appearance between OBRs and OBRl-
GFP in HEK293 cells since this cell line has previ-
ously been reported to express signi¢cant levels of
OBRs endogenously [16]. In surface biotinylation ex-
periments in cells expressing OBRl-GFP, we show
that OBRs appeared faster at the cell surface as com-
pared to OBRl-GFP upon leptin stimulation.
2. Materials and methods
2.1. Reagents and antibodies
RPMI 1640, fetal calf serum (FCS), phosphate
bu¡ered saline (PBS) and sodium pyruvate were all
purchased from Gibco (Paisley, UK). Protein-A Se-
pharose was from Pharmacia (Uppsala, Sweden).
The following antibodies were used: the anti-human
transferrin receptor (TfR) was obtained from Boehr-
inger Mannheim (Germany). An OBR polyclonal
antibody (K278) was produced by Neosystems
(Strasbourg) and was raised against a peptide in
the human leptin receptor corresponding to amino
acids 478^498 present in both the short and the
long form of the receptor. Texas red labelled donkey
secondary antibodies were from Amersham, and Cy3
labelling kits were obtained from Molecular Probes
(Oregon, USA). The pEGFP-N3 plasmid was from
Clontech (USA). Plasmid mini- and maxiprep kits
were from Qiagen (USA). Restriction enzymes and
alkaline phosphatase were obtained from Boehringer
Mannheim. Low melting preparative Grade Agarose
gels were from Bio-Rad Laboratories. Ligation was
performed according to Ready to go T4 DNA-ligase
from Amersham Pharmacia Biotech (USA).
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2.2. Cell culture, plasmids and transfection
SHSY5Y and HEK293 cells were grown in Dul-
becco’s modi¢ed Eagle’s medium (DMEM, Gibco,
UK) supplemented with 10% FCS and 5 mM gluta-
mine (Gibco) in a 5% humidi¢ed CO2 incubator.
cDNA encoding the full-length sequence of the hu-
man OBRl was cloned into the mammalian expres-
sion vector pCI-NEO (Promega, Madison, WI,
USA) and the C-terminus was fused to the N-termi-
nus of the gene for enhanced GFP (EGFP) from
pEGFP-N3 (Clontech). In the construct the mature
OBRl was found at the N-terminus to the human
IL3 signal peptide. The resulting construct, OBRl-
GFP, expressed the full-length OBRl fused at the
C-terminus with EGFP. Cells were transfected by
lipofection using the TransFast Transfection Reagent
(Promega) usually for 48 h before the experimental
procedures.
2.3. Internalization of endocytic markers
Leptin was conjugated with Cy3 (Molecular
Probes), according to the manufacturer’s instruc-
tions. For internalization of £uorophore-conjugated
leptin, cells were grown on 12 mm round coverslips
and incubated in DMEM medium supplemented
with 10% FCS, 4 mM glutamine in a 5% humidi¢ed
CO2 incubator for various times at 37‡C before they
were washed twice with ice cold PBS and ¢xed with
4% paraformaldehyde.
2.4. Immuno£uorescence
For immuno£uorescence experiments, cells were
grown on 12 mm round glass coverslips, prior to
¢xation and quenching in 50 mM glycine. Cells
were permeabilized in 0.2% saponin containing PBS
and 1% BSA. Cells were then double labelled with
antibodies against various proteins. As secondary
antibodies, we used donkey anti-IgG antibodies
coupled to FITC, Cy3 or marine blue (Molecular
Probes). When indicated cells were also treated
with 50 WM of the lysosomotropic reagent monensin
for 30 min before ¢xation. Coverslips were mounted
in Mowiol (Sigma). Double immuno£uorescence
analyses were examined with a Leica DMR-RXA
microscope (Leica Microsystems, Heerbrugg, Swit-
zerland) equipped with a three-chip charged-coupled
device (CCD) camera (C5810, Hamamatsu Pho-
tonics, Hamamatsu City, Japan). The images were
captured and quanti¢ed by densitometric analysis us-
ing a Bio-Rad Image analyser and processed with
Adobe Photoshop (Adobe Systems, Mountain
View, CA, USA).
2.5. STAT-Luciferase reporter assay
A reporter assay based on Stat3 signalling was
used to analyse the OBRl-GFP signalling capacities.
SHSY5Y cells were transiently cotransfected with a
plasmid containing luciferase as reporter gene
coupled to a Stat3 responsive element together with
either OBRl or OBRl-GFP. Non-transfected cells
were used as control. After 48 h of transfection cells
were treated with two di¡erent concentrations of lep-
tin, 25 nM and 2.5 nM respectively. After 20 h of
stimulation with leptin, the cells were lysed in Tris-
EDTA bu¡er containing 1% Triton X-100. The lu-
ciferase activity was measured according to the Lu-
ciferase Assay Kit instructions (BioThema, Sweden).
2.6. Cell lysis and Western blotting
HEK293 cell lysates were prepared by solving cells
in lysis bu¡er containing 150 mM NaCl, 20 mM
Tris-HCl, 5 mM EDTA, 1% Triton X-100, 0.5%
NP40 and 0.5% SDS, pH 7.4, and the lysates were
cleared by centrifugation (13 000Ug, 30 min). They
were then resolved on SDS-polyacrylamide gel elec-
trophoresis through 12% gradient polyacrylamide
gels from Novex and transferred to nitrocellulose
membranes (Amersham) using Novex Transblot cells
at 150 mA for 2 h. After transfer, the membranes
were blocked in 5% BSA for 1 h in blotting bu¡er
(PBS, 0.3% BSA and 0.05% Tween 20) at room tem-
perature, before incubation with antibodies. Mem-
branes were developed with the ECL kit (Amersham)
and exposed on Kodak xormat ¢lm.
2.7. Surface biotinylation experiments of OBRs and
OBRl-GFP
HEK293 cells were transfected with OBRl-GFP
and cultured in 10 cm petri dishes to 90% con£uence.
Non-transfected cells were used as control cells. The
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cells were serum starved for at least 4 h prior stim-
ulation with 2 nM leptin at various times and then
placed on ice, rinsed with cold PBS supplemented
with 0.5 mM MgCl2 and 1 mM CaCl2 (PBS++)
and surface labelled for 30 min on ice (surface label-
ling) using 1 mg/ml EZ-linked NHS-LC-biotin
(Pierce Chemical, Rockford, IL, USA) in PBS++.
After biotinylation, cells were rinsed twice with ice
cold PBS++ before harvested directly in lysis bu¡er
for immunoprecipitation for 4 h at 4‡C with anti-
bodies against OBRs (K278) or OBRl-GFP (GFP).
Immunoprecipitated biotinylated cell surface pro-
teins were eluted with sample bu¡er and resolved
by SDS-PAGE on 12% Novex gels and transferred
to nitrocellulose membranes and probed with HRP-
coupled streptavidin and developed by the ECL kit
(Amersham).
3. Results
3.1. Expression of OBRl-GFP in HEK293 cells
The human full-length OBRl was fused to GFP as
the schematic representation indicates in Fig. 1A.
Cell lysates from HEK293 cells transfected with an
empty plasmid (control cells), GFP only or the
OBRl-GFP chimera was analysed with antibodies
against OBR (K278) and GFP (anti-GFP) in West-
ern blotting (Fig. 1B). The K278 antibody detected
signi¢cant levels of endogenous OBRs with a molec-
ular size of approx. 150 kDa in control cells (Fig. 1B,
lane 1) as well as in GFP plasmid expressing cells
(Fig. 1B, lane 2). However, in Western blot analysis
of lysates from OBRl-GFP transfected cells (Fig. 1B,
lane 3) an additional band of about 200 kDa in mo-
lecular size was detected, corresponding to the pre-
dicted size of the recombinant OBRl-GFP chimera.
Western blotting with antibodies against GFP
yielded no speci¢c bands in control cells (Fig. 1B,
Fig. 1. Schematic presentation of the OBRl-GFP chimera and
immunoblot analysis of OBRl-GFP expression in HEK293 cells.
GFP was linked to the C-terminus of OBRl following removal
of the stop codon. Transmembrane regions (TM) and JAK and
Stat binding motifs are indicated (A). (B) HEK293 cells were
transiently transfected with empty vector (lanes 1 and 4), GFP
plasmid (lanes 2 and 5) or OBRl-GFP (lanes 3 and 6). Left
panel shows Western blotting with cell lysates examined with
antibodies against OBR (K278) (B, lanes 1^3). The right panel
shows Western blotting with antibodies against GFP (B, lanes
4^7). In HEK293 cells, transfected with an empty plasmid,
staining with K278 yielded an appropriate band around 150
kDa corresponding to OBRs (B, lane 1). In lysates from cells
transfected with GFP only (B, lanes 2 and 5), a strong band
around 26 kDa was observed when staining with antibodies
against GFP (B, lane 5). The same antibodies also recognized a
strong band around 200 kDa in lysates from cells transfected
with OBRl-GFP (B, lane 6). This band was also visible when
staining with the K278 antibody (B, lane 3). Lane 7 shows sea
blue standard markers and arrow points on 98 kDa.
Fig. 2. Leptin-induced activation of STAT. A reporter assay
based on Stat3 signalling was used to analyse the OBRl-GFP
signalling capacities. SHSY5Y cells were transfected with either
OBRl or OBRl-GFP for 48 h prior to stimulation with leptin
for 20 h. Cells were lysed and luciferase activity was measured.
A representative of two experiments is shown.
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lane 4) but recognized a strong band of approx. 26
kDa (Fig. 1B, lane 5). Moreover, in agreement with
the expected size of the recombinant OBRl-GFP chi-
mera, detection with GFP antibodies yielded a band
of approx. 200 kDa (Fig. 1B, lane 6).
3.2. Functional characterization of the OBRl-GFP
chimera in a STAT assay
To assess whether the leptin induced signalling ca-
pacity is maintained in the OBRl-GFP chimera, a
luciferase reporter assay was used. The stat reporter
contained a promoter speci¢c for stat activation
fused to the luciferase gene. SHSY5Y cells were co-
transfected with either OBRl or OBRl-GFP and a
stat luciferase reporter gene. After 48 h of transfec-
tion, cells were stimulated for 20 h with two di¡erent
concentrations of leptin, 25 nM and 2.5 nM respec-
tively. Results presented in Fig. 2 show that expres-
sion of OBRl and OBRl-GFP induced activation of
the luciferase reporter gene. Thus, the level of lucif-
erase induction observed with OBRl and OBRl-GFP
truly resulted from the ability of the receptors to
stimulate transcriptional activity of the stat luciferase
gene.
3.3. Expression and intracellular localization of
OBRl-GFP in HEK293 cells
In HEK293 cells transfected with the OBRl-GFP
chimera we observed a distinct green £uorescent ve-
sicular pattern spread throughout the cell interior
(Fig. 3A). The same cells were also used to study
subcellular localization of internalized £uorophore-
coupled leptin. In cells incubated with 2 nM Cy3-
conjugated leptin (Cy3-leptin) for 60 min at 37‡C
Fig. 3. Intracellular localization of GFP, OBRl-GFP and £uorophore-coupled leptin. In HEK293 cells transfected with OBRl-GFP a
green £uorescence was visible in intracellular vesicles spread throughout the cell interior (A). The same cells were internalized with
5 Wg/ml of Cy3-conjugated leptin for 60 min at 37‡C prior to ¢xation. Vesicles containing OBRl-GFP green £uorescence (A) and
Cy3-conjugated leptin (B) strongly colocalized in superimposition (D). Note a non-transfected cell in the lower part of the same image
that is not positive for OBRl-GFP £uorescence but for Cy3-leptin. Cells transfected with OBRl-GFP were also examined with poly-
clonal antibodies against GFP (D^F). The green OBRl-GFP £uorescence (D) was clearly colocalized with the GFP containing vesicles
detected with antibodies against GFP only (E). Superimposition of the same images is shown in F.
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(Fig. 3B), OBRl-GFP £uorescence and Cy3-leptin
displayed colocalized in a juxtapositional staining in-
dicating a receptor-ligand association in these
vesicles (Fig. 3C). In the same image but in the lower
part, a non-transfected cell is seen that does not ex-
press OBRl-GFP £uorescence but is positive for in-
ternalization with Cy3-leptin. This may con¢rm that
also cells expressing only endogenous OBRs are com-
petent in internalizing leptin. The intracellular ex-
pression of the OBRl-GFP chimera was also con-
¢rmed with polyclonal antibodies against GFP
itself in permeabilized cells (Fig. 3D^F). OBRl-GFP
green £uorescence (Fig. 3D) and GFP detected with
secondary antibodies in Cy3 red £uorescence (Fig.
3E) properly colocalized in superimposition images
(Fig. 3F). However, polyclonal antibodies against
GFP did not recognize the OBRl-GFP green £uores-
cent pattern in unpermeabilized cells (data not
shown).
3.4. Intracellular localization of OBRl-GFP and TfR
in HEK293 cells upon monensin treatment
Cells expressing OBRl-GFP (Fig. 4A) were la-
belled with antibodies against the human TfR for
immuno£uorescence. The TfR staining displayed a
punctuate vesicular pattern in the perinuclear area
(Fig. 4B) but was also found dispersed throughout
the cytoplasm in vesicles positive for OBRl-GFP
(Fig. 4A,B). In parallel, transfected HEK293 cells
were exposed to 50 WM monensin for 30 min before
¢xation. Monensin is a drug that prevents early en-
dosomal tra⁄cking by decreasing the pH of the en-
docytic vesicles, thus a¡ecting proteins that eventu-
ally recycle not to return back to the surface but
accumulate in early recycling endosomes. In monen-
sin-treated cells, the TfR accumulated in distinct
perinuclear structures characteristic of early recycling
endosomes (Fig. 4D), while OBRl-GFP £uorescence
Fig. 4. Intracellular localization of OBRl-GFP and TfR upon monensin treatment. HEK293 cells expressing OBRl-GFP (A) revealed
a bright punctuate vesicular staining. This staining pattern was partially in colocalization with the human TfR detected with monoclo-
nal antibodies against TfR (B). In cells pretreated with 50 WM monensin for 30 min prior to ¢xation, TfR positive vesicles were accu-
mulated in perinuclear vesicular regions recognized as early recycling endosomes (D), while the OBRl-GFP vesicle distribution re-
mained mainly unharmed in vesicles mostly negative for TfR (C).
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remained labelled with a more dispersed staining in
vesicles mainly negative for TfR (Fig. 4C).
3.5. Dissimilar receptor cell surface appearance of
OBRs and OBRl-GFP
For receptor transport studies, we took advantage
of a method based on surface biotinylation to mon-
itor di¡erences in intracellular transport and cell sur-
face appearance between OBRs and OBRl-GFP
upon leptin stimulation. Quantitative biochemical
analysis of OBRs and OBRl-GFP intracellular traf-
¢cking from the cell interior and the cell surface were
performed by incubating cells with 2 nM leptin for
10 min prior cell surface receptor biotinylation. We
estimated 10 min to be the most adequate period of
time for studying rapid cell surface appearance of
these receptors and to avoid interference of recycling
abilities in the measurements. These experiments re-
vealed that OBRs was recruited faster at the cell sur-
face as compared to OBRl-GFP since an increase of
35% was found at the cell surface for OBRs calcu-
lated from the initial amount at time point 0 (Fig. 5B
‘OBRs’). The corresponding ¢gure for OBRl-GFP
was only 12% (Fig. 5B ‘OBRl-GFP’).
4. Discussion
Hormone-receptor complexes may be taken up
into the cells and degraded in order to terminate
intracellular signalling. The existence of di¡erent in-
tracellular routes for receptor tra⁄cking may be an
important device to regulate receptor cell surface ap-
pearance and ligand retrieval. It is furthermore gen-
eral knowledge that for example insulin, insulin-like
growth factor, and transferrin receptors mediate
blood to brain transports through the brain capillary
endothelium by receptor-mediated endocytosis.
Moreover, receptor-mediated endocytosis has been
examined as a tool for drug delivery aimed at target-
ing drugs to speci¢c intracellular compartments
[23,24]. Carrier-drug complexes may be formed
with ligand or antibodies recognizing a certain recep-
tor [25,26].
It has been shown that the short forms of the OBR
are expressed throughout the body, whereas the ex-
pression of the long form has mainly been localized
to particular nuclei within the hypothalamus [8,9,15].
Mutations in the OBR gene are believed to underlie
the abnormalities in energy balance and plasma lep-
tin concentrations in certain animal models of obe-
sity and in some obese humans, possibly explained
by a reduced sensitivity to leptin resulting from such
mutations [27]. Recent studies on isolated human
brain microvessels support the idea that the choroid
plexa, sites of high expression of the short form of
the OBRs, serves as the site of leptin transport from
the serum to the cerebrospinal £uid [20]. Steady state
Fig. 5. Alternative cell surface appearance of OBRs and OBRl-
GFP. HEK293 cells non-transfected and transfected with
OBRl-GFP were stimulated with 2 nM leptin for 0 and 10 min
before cell surface biotinylation on ice for 30 min. Non-stimu-
lated cells were used as ‘time point 0 min’. Lysates were immu-
noprecipitated with antibodies against OBRs (K278) in non-
transfected cells and with antibodies against GFP for OBRl-
GFP detection in transfected cells. Biotinylated proteins were
detected with streptavidin-HRP in Western blotting (A). The
amount of OBRs at ‘time point 0 min’ was de¢ned as 100%.
The increase in cell surface biotinylated proteins after 10 min
was calculated from time point 0 min and quanti¢ed by densi-
tometric analysis using ImageQuant Software (B). Results
shown in A are representative of three experiments. Results
shown in B represent the mean þ S.E. of three independent ex-
periments.
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levels of circulating leptin would require an e⁄cient
system for distribution of leptin into the brain. Fur-
thermore, one may hypothesize that a massive in-
crease in blood leptin levels would require a quick
withdrawal of leptin from the plasma membrane into
the cell interior for storage and/or degradation in
order to prevent nonphysiological OBRl signalling.
OBRs appears to be a suitable candidate for both
these tasks. The receptor should then, in an e⁄cient
receptor recycling manner, after ligand dissociation,
reappear at the cell surface for another turn of inter-
nalization.
A number of di¡erent ligand-receptor complexes
are dissociated within the early endocytic compart-
ment at a pH of 6.2^6.5 [28], allowing free receptors
to recycle back to the plasma membrane and the li-
gand protein to shuttle to lysosomes for degradation.
Two hypotheses have been proposed for the organi-
zation of the endocytic compartment. The ‘matura-
tion model’ suggests a gradual maturation of clath-
rin-coated vesicles during their intracellular transport
[29]. The ‘vesicle shuttle model’ suggests transport
between preexisting endocytic organelles to be medi-
ated by transport [30,31]. Independent of the organi-
zation of the endocytic compartment, it is evident
that it contains sorting functions.
Since monensin is a cation ionophore with charac-
teristics of decreasing the pH of endocytic compart-
ments it is a¡ecting receptor-ligand dissociation and
degradation [32,33]. The TfR is traversing early sort-
ing endosomes before transport to early recycling
endosomes from where it cycles back to the cell sur-
face [34,35]. This pathway has been proven to be
monensin sensitive [32,33]. In immuno£uorescence,
we found OBRl-GFP not to accumulate in TfR pos-
itive vesicles indicating that OBRl-GFP probably
shuttles to degrading compartments after cell surface
internalization.
We have performed quantitative analysis of OBR
cell surface appearance in cell surface biotinylation
experiments. Total biotinylation (at 37‡C), resulted
in an intracellular accumulation of both OBRl-GFP
and OBRs. After 10 min of leptin stimulation, we
observed signi¢cant di¡erences between the amount
of biotinylated OBRs and OBRl-GFP at the cell sur-
face compared to time point 0. One may hypothesize
that the fast appearance of OBRs at the cell surface
upon leptin stimulation possibly may re£ect a more
pronounced recycling ability for this isoform. For
certain receptors, internalization is driven by the
presence of signal sequences, recognized by speci¢c
adaptor proteins. Studies on the subject of potential
endocytic sequence motifs in the carboxyl-terminal
tail of OBRs and OBRl are underway in our labo-
ratories. It is thus obvious that the di¡erent isoforms
of the OBR contain several signal sequences that are
known to function in clathrin-coated endocytosis.
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